Oscar Health (OSCR) rockets 22% on narrower Q4 loss and impressive 2024 guidance

Go back to Oscar Health (OSCR) rockets 22% on narrower Q4 loss and impressive 2024 guidance

Oscar Health Inc. (OSCR) Tops Q4 EPS by 6c; offers guidance

February 7, 2024 4:29 PM EST

Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($0.66), $0.06 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $1.43 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Oscar Health Inc. sees FY2024 revenue of $8.3-8.4 billion, versus the... More